MemeCore Hard Fork Sends Meme Market Higher After Upgrade
MemeCore completed its second-stage upgrade, slashing gas fees and enabling smoother on-chain activity. The move spar...
Volatile Markets Indices
Understand how volatile markets indices signal quick trends and what to watch for when assessing risk and opportunity in real time.
23,576 articles
No-Brainer Artificial Intelligence (AI) Stock to Skyrocket by 2026
AI is reshaping markets faster than many investors expect. This no-brainer artificial intelligence (AI) stock story b...
Tronic (KTCC) 2026 Earnings: A Small-Cap Investor Guide
As earnings season rolls in, KTCC’s tronic 2026 earnings story becomes a focal point for value seekers. This guide br...
Lam Research Surges 300% Year; Wall Street Sees More Gains
Lam Research shares jump on stronger AI-related demand for semiconductor equipment. With foundries expanding capacity...
Coinbase (COIN) 2026 Earnings: Q1 Deep Dive and Outlook
This comprehensive analysis breaks down Coinbase's Q1 2026 earnings, explaining revenue mix, margins, and the outlook...
Is It Too Late to Buy Late Advanced Micro Devices Stock?
AMD has surged dramatically, but the AI data-center boom could still offer upside. This guide explores whether late a...
Mizuho Hikes Dell Price Target on AI Server Demand
Mizuho raises Dell's price target to $300 on expected durable demand from agentic AI servers, while UBS nudges valuat...
KeyBanc Cuts Holding Price Target as Tariffs Pressure on Running Brand
KeyBanc lowers its price target for On Holding AG to $43, citing tariff exposure that weighs on margins, even as the ...
Internet Computer (ICP) Tumbles: Broad Selloff Deepens
The internet computer (icp) tumbles about 10% in a broad crypto selloff, weakening after Coinbase removed several ICP...
Why Figma Stock Jumped Friday: Q1 Beat Lifts Sentiment
Figma stunned traders with a big Q1 2026 beat, lifting the stock on Friday morning. Here’s what happened, why it matt...
BioHarvest (BHST) 2026 Earnings: Q1 Highlights and Outlook
As BioHarvest gears up for its Q1 2026 earnings, investors seek clarity on revenue momentum, margins, and the path to...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status